Loading...
ROCO
4102
Market cap24mUSD
Oct 08, Last price  
18.80TWD
1D
0.80%
1Q
-8.29%
Jan 2017
9.94%
IPO
12.51%
Name

Yung Zip Chemical Ind Co Ltd

Chart & performance

D1W1MN
ROCO:4102 chart
P/E
—
P/S
1.68
EPS
—
Div yield, %
6.12%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
0.47%
Revenues
474m
-18.76%
416,837,000463,212,000477,595,000567,331,000559,154,000583,695,000474,221,000
Net income
-14m
L
31,319,00030,742,0006,004,00069,993,00062,506,00064,605,000-14,364,000
CFO
2m
-98.23%
30,756,00036,067,00073,266,00092,553,00096,760,000118,671,0002,096,000
Dividend
Jul 04, 20251.15 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yung Zip Chemical Ind. Co., Ltd. is a global provider specializing in the manufacture of essential pharmaceutical components. The company supplies active pharmaceutical ingredients (APIs), their intermediate precursors, and various specialty chemicals to markets around the world. Their diverse product portfolio includes a wide array of therapeutic agents addressing conditions such as hypertension, iron overload, inflammation, pain, fever, fungal infections, schizophrenia, blood clotting issues, genital herpes outbreaks, and sleep disorders (hypnotics and sedatives). In addition to these core offerings, Yung Zip also provides pharmaceutical excipients, such as sodium starch glycolate, and offers bespoke research, development, and manufacturing services. The company, established in 1978, is headquartered in Taichung, Taiwan.

Key people

Ching Hwang Lin
Chairman of the Board, General Manager, Corporate Governance Officer · since 2024
Shuqin Xie
Head of Finance · since 2007
Yuru Li
General Manager · since 2025
Yandao Wu
Head of Accounting, Corporate Governance Officer · since 2025
Director · since 2025
Hongwen Jiang
Director · since 2007
Director · since 2022
Fang Chen Lee
Director · since 2018
Director · since 2022
Tingjun Lin
Director · since 2025
Yangzong Cai
Independent Director · since 2016
Shiuh-Tzung Liu
Independent Director · since 2025
Independent Director · since 2019
IPO date
Mar 20, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT